Raymond James Financial Inc. Has $60.71 Million Stock Holdings in The Cooper Companies, Inc. $COO

Key Points

• Raymond James Financial Inc. increased its holdings in The Cooper Companies by 2.1% to own approximately $60.71 million worth of shares as of the end of the last quarter.
• Cooper Companies reported $1 billion in revenue for the latest quarter, exceeding analyst expectations, with an earnings per share of $0.96.
• Research analysts have varied outlooks on Cooper Companies, with ratings ranging from Strong Buy to Hold, and a consensus price target set at $96.73.

Raymond James Financial Inc. increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 719,725 shares of the medical device company's stock after purchasing an additional 14,561 shares during the period. Raymond James Financial Inc. owned approximately 0.36% of Cooper Companies worth $60,709,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. American Century Companies Inc. raised its position in Cooper Companies by 0.9% in the first quarter. American Century Companies Inc. now owns 45,616 shares of the medical device company's stock worth $3,848,000 after purchasing an additional 406 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in Cooper Companies by 3.5% in the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company's stock worth $550,000 after purchasing an additional 220 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Cooper Companies by 4.1% in the first quarter. Dimensional Fund Advisors LP now owns 1,621,839 shares of the medical device company's stock worth $136,793,000 after purchasing an additional 63,681 shares in the last quarter. Horizon Investments LLC raised its position in Cooper Companies by 5.0% in the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after purchasing an additional 136 shares in the last quarter. Finally, Vestmark Advisory Solutions Inc. raised its position in Cooper Companies by 105.4% in the first quarter. Vestmark Advisory Solutions Inc. now owns 127,248 shares of the medical device company's stock worth $10,733,000 after purchasing an additional 65,294 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $73.50 on Thursday. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The firm has a market cap of $14.70 billion, a P/E ratio of 35.68, a P/E/G ratio of 1.81 and a beta of 1.00. The firm has a 50 day simple moving average of $72.02 and a 200 day simple moving average of $78.62. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. Cooper Companies's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Mizuho dropped their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a report on Tuesday, July 22nd. BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Finally, Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.